Cargando…

Identification and Validation of a Prognostic Prediction Model in Diffuse Large B-Cell Lymphoma

BACKGROUND: Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous group with varied pathophysiological, genetic, and clinical features, accounting for approximately one-third of all lymphoma cases worldwide. Notwithstanding that unprecedented scientific progress has been achieved over the years,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yan, Jiaqin, Yuan, Wei, Zhang, Junhui, Li, Ling, Zhang, Lei, Zhang, Xudong, Zhang, Mingzhi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9048048/ https://www.ncbi.nlm.nih.gov/pubmed/35498426 http://dx.doi.org/10.3389/fendo.2022.846357

Ejemplares similares

Decitabine combined with RDHAP regimen in relapsed/refractory diffuse large B cell lymphoma
por: Kong, Xiaoshuang, et al.
Publicado: (2023)

B7-CD28 gene family expression is associated with prognostic and immunological characteristics of diffuse large B-cell lymphoma
por: Wang, Gangjian, et al.
Publicado: (2019)

Ibrutinib in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Retrospective Study
por: Ren, Liangliang, et al.
Publicado: (2021)

Development and validation of a cuproptosis-associated prognostic model for diffuse large B-cell lymphoma
por: Zhang, Bingxin, et al.
Publicado: (2023)

An Atypical Presentation of Diffuse Large B-Cell Lymphoma
por: Garcês Soares, Sofia, et al.
Publicado: (2021)

A Multicenter Retrospective Study of 58 Patients With Primary Thyroid Diffuse Large B Cell Lymphoma
por: Yi, Jianing, et al.
Publicado: (2020)

Identification and Validation of a DNA Damage Repair-Related Signature for Diffuse Large B-Cell Lymphoma
por: Li, Yang, et al.
Publicado: (2022)

Identification and validation of 5-methylcytosine-associated genes in diffuse large B-cell lymphoma
por: Xing, Cheng, et al.
Publicado: (2023)

MYC overexpression but not MYC/BCL2 double expression predicts survival in bulky mass diffuse large B‐cell lymphoma patients
por: Wang, Yanjie, et al.
Publicado: (2023)

Identification and validation of a prognostic risk-scoring model based on sphingolipid metabolism-associated cluster in colon adenocarcinoma
por: Yuan, Qihang, et al.
Publicado: (2022)

Predictive and Prognostic Molecular Factors in Diffuse Large B-Cell Lymphomas
por: Pileri, Stefano A., et al.
Publicado: (2021)

Identification and Validation of a Prognostic Gene Signature for Diffuse Large B-Cell Lymphoma Based on Tumor Microenvironment-Related Genes
por: Pan, Tao, et al.
Publicado: (2021)

Apatinib in Patients with Relapsed or Refractory Diffuse Large B Cell Lymphoma: A Phase II, Open-Label, Single-Arm, Prospective Study
por: Ma, Xinran, et al.
Publicado: (2020)

Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Subtype of the Thyroid
por: Waqar, Syed Hamza Bin, et al.
Publicado: (2021)

RAC1, a Potential Diagnostic and Prognostic Marker for Diffuse Large B Cell Lymphoma
por: Wu, Xue, et al.
Publicado: (2022)

Prognostic implication of leucocyte subpopulations in diffuse large B-cell lymphoma
por: Han, Xiao, et al.
Publicado: (2017)

Genetically predicted C-reactive protein mediates the association between rheumatoid arthritis and atlantoaxial subluxation
por: Yuan, Jiaqin, et al.
Publicado: (2022)

Identification of Prognostic Related Genes of Tumor Microenvironment Derived From Esophageal Cancer Patients
por: Yuan, Wei, et al.
Publicado: (2021)

The Addition of Ferritin Enhanced the Prognostic Value of International Prognostic Index in Diffuse Large B‐Cell Lymphoma
por: Shen, Ziyuan, et al.
Publicado: (2022)

Establishment and evaluation of a nomogram for predicting the survival outcomes of patients with diffuse large B-cell lymphoma based on International Prognostic Index scores and clinical indicators
por: Chen, Yao, et al.
Publicado: (2023)

Corrigendum: Genetically predicted C-reactive protein mediates the association between rheumatoid arthritis and atlantoaxial subluxation
por: Yuan, Jiaqin, et al.
Publicado: (2023)

Identification of CXCR4 Upregulation in Diffuse Large B-Cell Lymphoma Associated with Prognostic Significance and Clinicopathological Characteristics
por: Zhang, Yi-an, et al.
Publicado: (2022)

Evaluation of latent membrane protein 1 and microRNA-155 for the prognostic prediction of diffuse large B cell lymphoma
por: Wu, Xue, et al.
Publicado: (2018)

Single-Cell RNA-Seq and Bulk RNA-Seq Reveal Intratumoral Heterogeneity and Tumor Microenvironment Characteristics in Diffuse Large B-Cell Lymphoma
por: Zhao, Yang, et al.
Publicado: (2022)

Prognostic analysis of CD5 expression in double-hit diffuse large B-cell lymphoma and effectiveness comparison in patients treated with dose-adjusted EPOCH plus rituximab/R-CHOP regimens
por: Zhang, Fangwen, et al.
Publicado: (2019)

Low Expression of 14-3-3beta Is Associated With Adverse Survival of Diffuse Large B-Cell Lymphoma Patients
por: Li, Chaoping, et al.
Publicado: (2019)

Identification of microtubule-associated biomarkers in diffuse large B-cell lymphoma and prognosis prediction
por: Wu, Wenqi, et al.
Publicado: (2023)

Identification of a prognostic metabolic gene signature in diffuse large B‐cell lymphoma
por: Wang, Huizhong, et al.
Publicado: (2021)

Identification and validation of a novel cuproptosis-related signature as a prognostic model for lung adenocarcinoma
por: Chen, Yuqiao, et al.
Publicado: (2022)

Deubiquitinase OTUD7B is a potential prognostic biomarker in diffuse large B-cell lymphoma
por: Qiu, Shi, et al.
Publicado: (2022)

Identification of a Prognostic 3-Gene Risk Prediction Model for Thyroid Cancer
por: Zhao, Haiping, et al.
Publicado: (2020)

A Prognostic Model of Gastrointestinal Diffuse Large B Cell Lymphoma
por: Gao, Fan, et al.
Publicado: (2021)

A modified prognostic model in patients with diffuse large B-cell lymphoma treated with immunochemotherapy
por: Zhao, Peiqi, et al.
Publicado: (2021)

Development and validation of nomogram prognostic model for predicting OS in patients with diffuse large B-cell lymphoma: a cohort study in China
por: Li, Xiaosheng, et al.
Publicado: (2023)

Prognostic significance of serum aspartic transaminase in diffuse large B-cell lymphoma
por: Lu, Ting-Xun, et al.
Publicado: (2019)

Corrigendum: Identification of microtube-associated biomarkers in diffuse large B-cell lymphoma and prognosis prediction
por: Wu, Wenqi, et al.
Publicado: (2023)

Expression and Prognostic Value of Glucose Transporter 3 in Diffuse Large B Cell Lymphoma
por: Xu, Yongpeng, et al.
Publicado: (2022)

Prognostic Nutritional Index Predicts Early Mortality in Diffuse Large B-cell Lymphoma
por: OZTURK, Erman, et al.
Publicado: (2022)

Identification of a 14-Gene Prognostic Signature for Diffuse Large B Cell Lymphoma (DLBCL)
por: Feng, Pengcheng, et al.
Publicado: (2021)

Proteomics Identifies Circulating TIMP-1 as a Prognostic Biomarker for Diffuse Large B-Cell Lymphoma
por: Lou, Ning, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_g6uuh1g7gjk1518bm52tqn0r01